Putting the ‘R’ & ‘D’ back into Ireland
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
Inflection Biosciences is developing small molecule therapeutics for the treatment of cancer. The company is creating a pipeline of highly innovative cancer treatments through alliances with leading cancer research organisations. The pipeline includes unique dual mechanism kinase inhibitors and PIM kinase inhibitors in preclinical development
Cancer continues to be a major threat to human health globally. While progress has been made, much more needs to be achieved to provide better treatment solutions for patients. Our research and development focus targets major unmet medical needs in cancer.
Contact
Address: Suite 15, Anglesea House Carysfort Avenue, Blackrock, Co. Dublin
Tel: +353 1 400 3615
Website: www.inflectionbio.com
Email: info@inflectionbio.com
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
Darren Cunningham tells us the story behind Inflection Biosciences (and its name), the rationale of focusing on small molecule cancer treatments, his thoughts on the Irish biotech start-up scene, and his hopes…
See our Cookie Privacy Policy Here
